Ireland
Nuritas, founded in 2014 and headquartered in Ireland, leverages its cutting-edge AI to discover cell-signaling peptides for smarter product formulations. With the slogan "Peptide Intelligence for Smarter Formulations," the company aims to enhance consumer products, making them healthier, safer, greener, and more effective.
Their AI-driven solutions are validated through human clinical studies, ensuring the safety and efficacy of their unique ingredients. Nuritas is positioned at the intersection of technology and nature, translating the wisdom of nature into modern innovations.
In their latest funding round on 01 December 2024, they secured a substantial $42.00M Series C investment. Key investors include M&G Investments, McWin Partners, European Circular Bioeconomy Fund, and Grosvenor Food & AgTech. This capital infusion will likely propel their mission to revolutionize product formulations and expand their market footprint.
